Healthcare Business

Hazmat

Lakeland Private Placement Comes at Severe Discount to Ebola Trade

Lakeland Industries Inc. (NASDAQ: LAKE) announced that it had entered into a definitive securities purchase agreement to raise approximately $11.2 million in a private placement of common stock, sold at ...
Read Full Story »
Pfizer

Pfizer Stock Buyback Plan Just Too Large to Ignore — It Is on Viagra

A Pfizer Inc. (NYSE: PFE) press release on Thursday evening was honestly given the wrong title by the company's investor relations department. The new release titled "Pfizer Declares 26-Cent Fourth-Quarter ...
Read Full Story »
DNA

Will Celgene Become the Next $100 Billion Biotech Stock?

Does Celgene Corporation (NASDAQ: CELG) have what it takes to make it to a $100 billion market cap? Some analysts would think so, following the favorable release of this biotech ...
Read Full Story »
135093244

Companies That Benefit as Sexually Transmitted Disease Cases Keep Growing

Although it is a subject many investors would like to avoid, for obvious reasons, the growth in the number of sexually transmitted diseases (or STDs, as they are called) is ...
Read Full Story »
Boston Scientific

After Multiyear Turnaround, Is Boston Scientific Finally (and Really) Back?

Boston Scientific Corp. (NYSE: BSX) reported third-quarter results of $0.20 in earnings per share and $1.85 billion in revenue. That was against Thomson Reuters consensus estimates of $0.20 in earnings ...
Read Full Story »
Pills

3 Irish Specialty Pharmaceutical Stocks to Buy After Tax Inversion Implosion

For now, while the benefit for American corporations to buy or merge and move overseas may be over, as evidenced by AbbVie cancelling its merger with Shire Pharmaceutical, that doesn't ...
Read Full Story »
biotech

Biogen Takes Breather on Earnings and MS Drug Sales

Biogen Idec Inc. (NASDAQ: BIIB) reported its third-quarter results before the market opened Wednesday as $3.80 in earnings per share and $2.5 billion in revenue. That was against Thomson Reuters ...
Read Full Story »
Stock Split Image

The Plan to Drive Amgen Shares Up Over 70%

Amgen Inc. (NASDAQ: AMGN) used to be the king of biotech by size. That was then, and now is the time for a break-up or other efforts. At least that ...
Read Full Story »
biotech

Why Everyone Likes Illumina Again

Illumina Inc. (NASDAQ: ILMN) reported its earnings before the market opened Monday as $0.77 in earnings per share and $481 in revenue which beat out consensus estimates. On the heels ...
Read Full Story »
initial public offering

Connecture Files for IPO: Health Care Insurance Platform

Connecture Inc. has filed its S-1 form with the U.S. Securities and Exchange Commission (SEC) to have an initial public offering (IPO). No terms were given for the offering, but ...
Read Full Story »
health care

Goldman Sachs Analyst Neutral Rating of MannKind Feels Like Downgrade

There had been some brief hopes that the worst was over for struggling MannKind Corp. (NASDAQ: MNKD). It turns out that not all great FDA approvals end up being great ...
Read Full Story »
Ebola Virus

Ebola Stock Fallout Severe on Monday

Is the Ebola scare over in the United States? Probably not by a long shot. That being said, Ebola fears are subsiding on Monday as dozens of people came off ...
Read Full Story »
Merger

NewLink Scores Major Partners With Roche’s Genentech

NewLink Genetics Corp. (NASDAQ: NLNK) announced that it has entered into an exclusive worldwide license agreement with Genentech, a member of the Roche Group, for the development of NLG919, NewLink's ...
Read Full Story »
research

Merrill Lynch’s 5 Destroyed Biotech Stocks With 100% or More Upside Potential

While Friday was a welcome relief for shell-shocked stock investors, much of the damage that has been inflicted since the start of the quarter is still weighing on some top ...
Read Full Story »
Ebola Virus

Ebola Stocks Move in Different Directions

Recently we have seen a surge in Ebola-related stocks across the board, but Friday trading brings a mixed view for this group. Allied Healthcare Products Inc. (NASDAQ: AHPI) in Friday ...
Read Full Story »